Somatic Mutations in Thyroid Nodular Disease

This publication has 66 references indexed in Scilit:

• The Thyrotropin Receptor Mutation Database
  Thyroid®, 1999
• Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades
  Molecular Endocrinology, 1995
• Role of the cyclic adenosine 3',5'-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices
  Journal of Clinical Endocrinology & Metabolism, 1994
• Germline mutations in the thyrotropin receptor gene cause non–autoimmune autosomal dominant hyperthyroidism
  Nature Genetics, 1994
• Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
  Nature, 1993
• Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors
  Physiological Reviews, 1992
• G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity.
  Proceedings of the National Academy of Sciences, 1991
• Two G Protein Oncogenes in Human Endocrine Tumors
  Science, 1990
• GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
  Nature, 1989
• The cyclic AMP-mediated stimulation of cell proliferation
  Trends in Biochemical Sciences, 1989